Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Wolfe Research analyst Mike Polark initiates coverage on Medtronic (NYSE:MDT) with a Underperform rating.

Analyst Boost H&R Block Price Target But Still Cautious On Long-Term Growth: Here’s Why

By Lekha Gupta

August 16, 2:50 PM

A couple of analysts boosted the price target of H&R Block Inc (NYSE: HRB) following

HRB

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

June 28, 1:04 PM

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

ACHR

Analyst Ratings

Analyst Ratings for Fabrinet

By Benzinga Insights

June 12, 8:07 AM

Fabrinet (NYSE:FN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

Comparative Study: AbbVie And Industry Competitors In Biotechnology Industry

By Benzinga Insights

June 11, 11:00 AM

In today’s fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct…

ABBV

Wolfe Research Initiates Coverage On Medtronic with Underperform Rating

Related Posts

Analyst Boost H&R Block Price Target But Still Cautious On Long-Term Growth: Here’s Why

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

Analyst Ratings for Fabrinet

Comparative Study: AbbVie And Industry Competitors In Biotechnology Industry